The {pharmaceutical market is rapidly exploring innovative treatment approaches for obesity , and the emergence of semaglutide 10mg doses represents a change. Healthcare providers are beginning to assess the possible benefits and drawbacks associated with this stronger strength product, especially in contrast with existing lower-dose semaglutide th